Most cancer-associated mutations occur within the DBD, causing structural alterations (e.g., R175, Y220, G245) or impacting DNA binding (e.g., R248 and R273) [54], which makes DBD crucial for the tumor-suppressive functions of p53. Here, TP53 is linked to cancer.